Wednesday, October 20, 2021

Sales of Biogen’s costly new Alzheimer’s drug fall far short of expectations.


By BY REBECCA ROBBINS from NYT Business https://ift.tt/3n9yBwd
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

ads

t>
Powered by Blogger.